2018
DOI: 10.1016/j.bcp.2018.06.024
|View full text |Cite
|
Sign up to set email alerts
|

Interactions of endocannabinoid virodhamine and related analogs with human monoamine oxidase-A and -B

Abstract: The endocannabinoid system plays an important role in the pathophysiology of various neurological disorders, such as anxiety, depression, neurodegenerative diseases, and schizophrenia; however, little information is available on the coupling of the endocannabinoid system with the monoaminergic systems in the brain. In the present study, we tested four endocannabinoids and two anandamide analogs for inhibition of recombinant human MAO-A and -B (monoamine oxidase). Virodhamine inhibited both MAO-A and -B (IC val… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 50 publications
0
8
0
Order By: Relevance
“…Exact structure: endogenous peroxisome proliferator-activated receptor alpha (PPAR-α) agonist (Gaetani et al 2003), antitussive activity (Wortley et al 2017), anti-inflammatory activity (Toguri et al 2018), used to treat post-traumatic stress disorder by fatty acid amide hydrolase (FAAH) inhibition (Danandeh et al 2018), useful in the treatment of neurological disorders (Pandey et al 2018), anti-nausea effect (Rock et al 2017), analgesic activity (Zubrzycki et al 2017), anticancer activity against colon cancer cells (Pagano et al 2017)…”
Section: Resultsmentioning
confidence: 99%
“…Exact structure: endogenous peroxisome proliferator-activated receptor alpha (PPAR-α) agonist (Gaetani et al 2003), antitussive activity (Wortley et al 2017), anti-inflammatory activity (Toguri et al 2018), used to treat post-traumatic stress disorder by fatty acid amide hydrolase (FAAH) inhibition (Danandeh et al 2018), useful in the treatment of neurological disorders (Pandey et al 2018), anti-nausea effect (Rock et al 2017), analgesic activity (Zubrzycki et al 2017), anticancer activity against colon cancer cells (Pagano et al 2017)…”
Section: Resultsmentioning
confidence: 99%
“…The in vitro enzyme-inhibition assay was designed to measure the effect of primaquine and NPC1161 enantiomers on catalytic activity of r hMAO-A and -B. The kynuramine oxidative deamination assay was performed in white flat-bottom 96-well plates as previously described, with minor modifications [ 63 , 70 ]. A fixed concentration of kynuramine substrate and varying concentrations of the test compounds were used to determine the IC 50 values.…”
Section: Methodsmentioning
confidence: 99%
“…The control set without inhibitor was also run simultaneously. The results were analyzed in SigmaPlot version 10 using standard double reciprocal Lineweaver–Burk plots for computing Km and Vmax values, which were further analyzed to determine the Ki values [ 63 ].…”
Section: Methodsmentioning
confidence: 99%
“…All of the samples were dialyzed against potassium phosphate buffer (25 mM; pH 7.4) at 4 °C for 14–18 h (three buffer changes). Control enzyme (without inhibitor) was also run through the same procedure and the activity of the enzyme was determined before and after the dialysis [ 18 ].…”
Section: Methodsmentioning
confidence: 99%